Budget impact analysis in economic evaluation: a proposal for a clearer definition Livio GarattiniKatelijne van de Vooren Editorial 27 August 2011 Pages: 499 - 502
Comparison of cost-weights scales methodologies in the perspective of a financing system based on pathologies M. PirsonC. DeloP. Leclercq Original Paper 04 July 2010 Pages: 503 - 508
Cost efficiency of university hospitals in the Nordic countries: a cross-country analysis Emma MedinKjartan S. AnthunClas Rehnberg Original Paper 29 July 2010 Pages: 509 - 519
Do you believe in magic? Improving the quality of pharmacy services through restricting entry and aspirational contracts, the Irish experience Paul K. Gorecki Original Paper 09 July 2010 Pages: 521 - 531
Direct costs of Alzheimer’s disease in Germany Peter KienckeDietmar DanielReinhard Rychlik Original Paper 18 July 2010 Pages: 533 - 539
Exploring the relationship between costs and quality: Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments? Anne HvenegaardJacob Nielsen ArendtDorte Gyrd-Hansen Original Paper 02 August 2010 Pages: 541 - 551
How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives Özden Gür AliBaşak Topaler Original Paper 18 August 2010 Pages: 553 - 562
The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain Iván Moreno-TorresJaume Puig-JunoyJosep M. Raya Original Paper 01 September 2010 Pages: 563 - 573
Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom M. F. BottemanM. MeijboomS. Kaura Original Paper Open access 31 August 2010 Pages: 575 - 588
Market structure and hospital–insurer bargaining in the Netherlands R. S. HalbersmaM. C. MikkersI. Seinen Original Paper Open access 19 September 2010 Pages: 589 - 603